Trayhurn Paul, Wood I Stuart
Neuroendocrine and Obesity Biology Unit, Liverpool Centre for Nutritional Genomics, School of Clinical Sciences, University of Liverpool, UK.
Br J Nutr. 2004 Sep;92(3):347-55. doi: 10.1079/bjn20041213.
White adipose tissue is now recognised to be a multifunctional organ; in addition to the central role of lipid storage, it has a major endocrine function secreting several hormones, notably leptin and adiponectin, and a diverse range of other protein factors. These various protein signals have been given the collective name 'adipocytokines' or 'adipokines'. However, since most are neither 'cytokines' nor 'cytokine-like', it is recommended that the term 'adipokine' be universally adopted to describe a protein that is secreted from (and synthesised by) adipocytes. It is suggested that the term is restricted to proteins secreted from adipocytes, excluding signals released only by the other cell types (such as macrophages) in adipose tissue. The adipokinome (which together with lipid moieties released, such as fatty acids and prostaglandins, constitute the secretome of fat cells) includes proteins involved in lipid metabolism, insulin sensitivity, the alternative complement system, vascular haemostasis, blood pressure regulation and angiogenesis, as well as the regulation of energy balance. In addition, there is a growing list of adipokines involved in inflammation (TNFalpha, IL-1beta, IL-6, IL-8, IL-10, transforming growth factor-beta, nerve growth factor) and the acute-phase response (plasminogen activator inhibitor-1, haptoglobin, serum amyloid A). Production of these proteins by adipose tissue is increased in obesity, and raised circulating levels of several acute-phase proteins and inflammatory cytokines has led to the view that the obese are characterised by a state of chronic low-grade inflammation, and that this links causally to insulin resistance and the metabolic syndrome. It is, however, unclear as to the extent to which adipose tissue contributes quantitatively to the elevated circulating levels of these factors in obesity and whether there is a generalised or local state of inflammation. The parsimonious view is that the increased production of inflammatory cytokines and acute-phase proteins by adipose tissue in obesity relates primarily to localised events within the expanding fat depots. It is suggested that these events reflect hypoxia in parts of the growing adipose tissue mass in advance of angiogenesis, and involve the key controller of the cellular response to hypoxia, the transcription factor hypoxia inducible factor-1.
白色脂肪组织现在被认为是一个多功能器官;除了脂质储存的核心作用外,它还具有主要的内分泌功能,可分泌多种激素,特别是瘦素和脂联素,以及多种其他蛋白质因子。这些不同的蛋白质信号被统称为“脂肪细胞因子”或“脂肪因子”。然而,由于大多数既不是“细胞因子”也不是“细胞因子样”,建议普遍采用“脂肪因子”一词来描述由脂肪细胞分泌(并合成)的蛋白质。建议该术语仅限于脂肪细胞分泌的蛋白质,不包括仅由脂肪组织中的其他细胞类型(如巨噬细胞)释放的信号。脂肪因子组(与释放的脂质部分,如脂肪酸和前列腺素一起,构成脂肪细胞的分泌组)包括参与脂质代谢、胰岛素敏感性、替代补体系统、血管止血、血压调节和血管生成以及能量平衡调节的蛋白质。此外,越来越多的脂肪因子参与炎症反应(肿瘤坏死因子α、白细胞介素-1β、白细胞介素-6、白细胞介素-8、白细胞介素-10、转化生长因子-β神经生长因子)和急性期反应(纤溶酶原激活物抑制剂-1、触珠蛋白、血清淀粉样蛋白A)。肥胖时脂肪组织中这些蛋白质的产生增加,几种急性期蛋白和炎性细胞因子的循环水平升高,导致人们认为肥胖者的特征是慢性低度炎症状态,并且这与胰岛素抵抗和代谢综合征存在因果联系。然而,尚不清楚脂肪组织在肥胖时对这些因子循环水平升高的定量贡献程度,以及是否存在全身性或局部炎症状态。一种简约的观点认为,肥胖时脂肪组织中炎性细胞因子和急性期蛋白产生的增加主要与不断扩大的脂肪库内的局部事件有关。有人认为,这些事件反映了血管生成之前生长中的脂肪组织部分的缺氧情况,并涉及细胞对缺氧反应的关键调控因子,即转录因子缺氧诱导因子-1。